Lyumjev (insulin lispro-aabc) for the Treatment of Type 1 and Type 2 Diabetes

The FDA approval of Lyumjev was based on the findings from PRONTO clinical trial programme. Credit: Eli Lilly and Company.



  • Lyumjev (insulin lispro-aabc)
  • Lyumjev (insulin lispro-aabc)
  • Lyumjev (insulin lispro-aabc)
  • Lyumjev (insulin lispro-aabc)